Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 86

Sort by

Sort Order Select

Journal Articles

Platelet dysfunction reversal with cold-stored vs room temperature–stored platelet transfusions

Valery J. Kogler, Jeffrey A. Miles, Tahsin Özpolat, S. Lawrence Bailey, Daire A. Byrne, Morgan Bawcom-Randall, Yi Wang, Hannah J. Larsen, Franklin Reed, Xiaoyun Fu, Moritz Stolla

Blood (2024) 143 (20): 2073–2088.

https://doi.org/10.1182/blood.2023022593

Published: 2024

Includes: Supplemental data

Journal Articles

A Phase I Study of Venetoclax Combined with Homoharringtonine, Cytarabine, and G-CSF for the Treatment of Pediatric De Novo Acute Myeloid Leukemia

Shengqin Cheng, Li Gao, Yi Wang, Peifang Xiao, Hailong He, Jun Lu, Jie Li, Yixin Hu, Liyan Fan, Raul C. Ribeiro, Cheng Cheng, Shaoyan Hu

Blood (2023) 142 (Supplement 1): 2900.

https://doi.org/10.1182/blood-2023-188040

Published: 2023

Journal Articles

Bioactive Lipid Mediators Predict Platelet Function in Transfusion Recipients: A Phase 1 Randomized Clinical Trial in Healthy Humans

Valery J Kogler, Jeffrey Miles, Hasan Tahsin Ozpolat, Shawn Bailey, Daire Byrne, Morgan Bawcom-Randall, Yi Wang, Hannah Larsen, Franklin Reed, Xiaoyun Fu, Moritz Stolla

Blood (2023) 142 (Supplement 1): 1287.

https://doi.org/10.1182/blood-2023-180307

Published: 2023

Journal Articles

Mitoxantrone Hydrochloride Liposome, Gemcitabine, Vinorelbine with or without Rituximab (GVM±R) in Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Wei Liu, Yi Wang, Yan Xu, Chenxing Du, Qi Wang, Tingyu Wang, Wenyang Huang, Shuaishuai Zhang, Shuhua Yi, Yuting Yan, Tengteng Yu, Weiwei Sui, Gang An, Rui Lyu, Huimin Liu, Wenjie Xiong, Mingwei Fu, Dehui Zou, Lugui Qiu

Blood (2023) 142 (Supplement 1): 6232.

https://doi.org/10.1182/blood-2023-185669

Published: 2023

Journal Articles

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Blood (2023) 142 (Supplement 1): 4754.

https://doi.org/10.1182/blood-2023-180736

Published: 2023

Journal Articles

Outcomes of Children and Adolescents with Acute Myeloid Leukemia Given a Low-Versus Standard-Dose Chemotherapy Regimen for Remission Induction (CALSIII-AML18): A Multicenter, Phase 3, Randomized, Noninferiority Trial

Blood (2023) 142 (Supplement 1): 729.

https://doi.org/10.1182/blood-2023-189253

Published: 2023

Journal Articles

A Multicenter Clinical Study with Reduced Intensive Chemotherapy for Induction Remission of Pediatric Acute Megakaryoblastic Leukemia

Blood (2023) 142 (Supplement 1): 4276.

https://doi.org/10.1182/blood-2023-190821

Published: 2023

Journal Articles

Self-Association of Von Willebrand Factor (VWF) into Prothrombotic Fibers Is Most Potently Enhanced By the Highly Atherogenic Small, Dense Fraction of Low-Density Lipoprotein (sd-LDL)

Junmei Chen, Forrest Nussdorfer, Raymond Adili, Kimsey Platten, Nicole Rhoads, Richard Maldonado, Franklin Reed, Yi Wang, Minhua Ling, Sergio Fazio, Xiaoyun Fu, Nathalie Pamir, Jose A. Lopez, Dominic W. Chung

Blood (2023) 142 (Supplement 1): 504.

https://doi.org/10.1182/blood-2023-188325

Published: 2023

Journal Articles

Decitabine Combined with Low-Dose Chemotherapy Is Effective in the Treatment of Pediatric Refractory/Relapsed Acute Myeloid Leukemia

Liyan Fan, Hua Jiang, Hongjun Liu, Ning Liao, Ningling Wang, Xiaowen Zhai, Xiuli Ju, Yufeng Liu, Jixia Luo, Peifang Xiao, Jun Lu, Hailong He, Yi Wang, Raul C. Ribeiro, Shaoyan Hu

Blood (2023) 142 (Supplement 1): 2905.

https://doi.org/10.1182/blood-2023-191115

Published: 2023

Journal Articles

High Level of IL-16 Secreted By Non-GCB DLBCL Facilitates Tumor Growth Though the Tumor-Promoting and Immunosuppressive Tumor Microenvironment

Xuwen Guan, Teng Fang, Yi Wang, Wei Liu, Mu Hao, Lugui Qiu

Blood (2023) 142 (Supplement 1): 6080.

https://doi.org/10.1182/blood-2023-180840

Published: 2023

Journal Articles

Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association

Dominic W. Chung, Kimsey Platten, Koya Ozawa, Reheman Adili, Nathalie Pamir, Forrest Nussdorfer, Alexander St. John, Minhua Ling, Jennie Le, Jeff Harris, Nicole Rhoads, Yi Wang, Xiaoyun Fu, Junmei Chen, Sergio Fazio, Jonathan R. Lindner, José A. López

Blood (2023) 142 (13): 1156–1166.

https://doi.org/10.1182/blood.2023019749

Published: 2023

Includes: Multimedia, Supplemental data

Journal Articles

GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT

Dongyao Wang, Zimin Sun, Xiaoyu Zhu, Xiaohu Zheng, Yonggang Zhou, Yichen Lu, Peidong Yan, Huiru Wang, Huilan Liu, Jing Jin, Huaiping Zhu, Rui Sun, Yi Wang, Binqing Fu, Zhigang Tian, Haiming Wei

Blood (2022) 140 (26): 2788–2804.

https://doi.org/10.1182/blood.2022015474

Published: 2022

Includes: Supplemental data

Journal Articles

Clinical Efficacy Observation of Humanized BCMA-CAR-T in the Treatment of Relapsed/Refractory Multiple Myeloma Complicated with Extramedullary Lesions

Yi Wang, Hui Wang, Ben Niu, Ying Gao, Ding Zhang, Yudi Miao, Wei Zhou, Limin Hou, Hong Zhang, Xingxing Hu, Fangyuan Wang, Lan Li, Xingli Ru, Weihua Zhang, Xiang Li, Feng Guan

Blood (2022) 140 (Supplement 1): 10287.

https://doi.org/10.1182/blood-2022-168561

Published: 2022

Journal Articles

Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial

Blood (2022) 140 (Supplement 1): 5543–5545.

https://doi.org/10.1182/blood-2022-162945

Published: 2022

Journal Articles

Iron Chelation of Hetrombopag in Aplastic Anemia: A Post Hoc Analysis of a Phase II Study

Wenrui Yang, Xin Zhao, Guangsheng He, Hong Chang, Bing Han, Sujun Gao, Shunqing Wang, Tong Chen, Fei Li, Yi Wang, Xiaoyan Ge, Rong Fu, Zheng Ge, Yingmei Li, Hong Liu, Xinjian Liu, Miao Miao, Liansheng Zhang, Fengkui Zhang

Blood (2022) 140 (Supplement 1): 5809–5810.

https://doi.org/10.1182/blood-2022-164560

Published: 2022

Journal Articles

Single Institution Observational Study of Risk-Adapted Therapy for Children with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia

Yixin Hu, Li Gao, Peifang Xiao, Hailong He, Yi Wang, Liyan Fan, Shengqin Cheng, Jing Ling, Jie Li, Junjie Fan, Yanhua Yao, Xin Ding, Jian Pan, Jun Lu, Raul C. Ribeiro, Shaoyan Hu

Blood (2022) 140 (Supplement 1): 11809.

https://doi.org/10.1182/blood-2022-170708

Published: 2022

Journal Articles

The N-Terminal Amino Acid Mutation Site Is a Potential Biological Marker for Precise Risk Stratification in Pediatric Patients with CEBPA-Dm AML

Shengqin Cheng, Yixin Hu, Li Gao, Liyan Fan, Yi Wang, Hailong He, Jie Li, Jun Lu, Peifang Xiao, Shaoyan Hu

Blood (2022) 140 (Supplement 1): 11841.

https://doi.org/10.1182/blood-2022-170955

Published: 2022

Journal Articles

Racial Difference in Part D Enrollment and Survival Among Older Patients with Multiple Myeloma

Rong Wang, Natalia Neparidze, Xiaomei Ma, Graham A Colditz, Su-Hsin Chang, Shi-Yi Wang

Blood (2022) 140 (Supplement 1): 5270–5271.

https://doi.org/10.1182/blood-2022-164741

Published: 2022

Journal Articles

R-DA-Edoch/R-DHAP Alteration Could Overcome High Risk Factors in Younger Mantle Cell Lymphoma

Shuhua Yi, Yi Wang, Yuting Yan, Jiawen Chen, Wei Liu, Tingyu Wang, Gang An, Weiwei Sui, Wenyang Huang, Xiong Wenjie, Huimin Liu, Qi Sun, Huijun Wang, Zhijian Xiao, Jianxiang Wang, Dehui Zou, Lugui Qiu

Blood (2022) 140 (Supplement 1): 6512–6513.

https://doi.org/10.1182/blood-2022-165237

Published: 2022

Journal Articles

SC-gtCAR19, a Non-Viral Genome Targeting Anti-CD19 CAR-T Candidate in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: Updated Results from Long-Term Follow-up

Hui Wang, Ying Gao, Ding Zhang, Yan Zheng, Xingxing Hu, Qiuying Gao, Ben Niu, Limin Hou, Ling Wang, Weihua Zhang, Yi Zhang, Xingli Ru, Le Li, Zuohan Peng, Yi Wang

Blood (2022) 140 (Supplement 1): 4623–4624.

https://doi.org/10.1182/blood-2022-159871

Published: 2022

NARROW

Platelet dysfunction reversal with cold-stored vs room temperature–stored platelet transfusions

A Phase I Study of Venetoclax Combined with Homoharringtonine, Cytarabine, and G-CSF for the Treatment of Pediatric De Novo Acute Myeloid Leukemia

Bioactive Lipid Mediators Predict Platelet Function in Transfusion Recipients: A Phase 1 Randomized Clinical Trial in Healthy Humans

Mitoxantrone Hydrochloride Liposome, Gemcitabine, Vinorelbine with or without Rituximab (GVM±R) in Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study

Outcomes of Children and Adolescents with Acute Myeloid Leukemia Given a Low-Versus Standard-Dose Chemotherapy Regimen for Remission Induction (CALSIII-AML18): A Multicenter, Phase 3, Randomized, Noninferiority Trial

A Multicenter Clinical Study with Reduced Intensive Chemotherapy for Induction Remission of Pediatric Acute Megakaryoblastic Leukemia

Self-Association of Von Willebrand Factor (VWF) into Prothrombotic Fibers Is Most Potently Enhanced By the Highly Atherogenic Small, Dense Fraction of Low-Density Lipoprotein (sd-LDL)

Decitabine Combined with Low-Dose Chemotherapy Is Effective in the Treatment of Pediatric Refractory/Relapsed Acute Myeloid Leukemia

High Level of IL-16 Secreted By Non-GCB DLBCL Facilitates Tumor Growth Though the Tumor-Promoting and Immunosuppressive Tumor Microenvironment

Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association

GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT

Clinical Efficacy Observation of Humanized BCMA-CAR-T in the Treatment of Relapsed/Refractory Multiple Myeloma Complicated with Extramedullary Lesions

Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial

Iron Chelation of Hetrombopag in Aplastic Anemia: A Post Hoc Analysis of a Phase II Study

Single Institution Observational Study of Risk-Adapted Therapy for Children with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia

The N-Terminal Amino Acid Mutation Site Is a Potential Biological Marker for Precise Risk Stratification in Pediatric Patients with CEBPA-Dm AML

Racial Difference in Part D Enrollment and Survival Among Older Patients with Multiple Myeloma

R-DA-Edoch/R-DHAP Alteration Could Overcome High Risk Factors in Younger Mantle Cell Lymphoma

SC-gtCAR19, a Non-Viral Genome Targeting Anti-CD19 CAR-T Candidate in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: Updated Results from Long-Term Follow-up

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only